Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Jan;108(1):139–145. doi: 10.1111/j.1476-5381.1993.tb13453.x

Selective IK blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia and reperfusion arrhythmias in rat and rabbit hearts.

S A Rees 1, M J Curtis 1
PMCID: PMC1907696  PMID: 8428204

Abstract

1. UK66,914 is a specific and selective blocker of the delayed rectifying potassium current (IK). The effectiveness of IK block as a mechanism for prevention of ischaemia- and reperfusion-induced arrhythmias was tested by use of UK66,914: its actions in rat, a species deficient in cardiac IK were compared with its actions in rabbit, a species possessing functional cardiac IK. Antiarrhythmic actions in rabbit but none in rat is the only outcome possible if selective IK blockade is responsible for the antiarrhythmic actions of the drug during ischaemia and/or reperfusion. 2. During 30 min regional ischaemia, 0.3 and 1 microM UK66,914 had no influence on the incidence of ventricular fibrillation (VF) in rat (n = 9/group), values being 78% in controls, 100% in 0.3 microM-treated hearts and 78% in 1.0 microM-treated hearts (NS). UK66,914 also had no effect on reperfusion-induced VF incidence (100% in each group), nor on the latency to onset of ischaemia- or reperfusion-induced arrhythmias. In contrast, in rabbit (n = 13/group), similar concentrations of drug reduced the incidence of reperfusion-induced VF from 77% in controls, to 38% and 31% (P < 0.05) respectively. The incidence of ischaemia-induced arrhythmias was too low in controls to permit detection of an antiarrhythmic effect in rabbit; however no drug-induced proarrhythmia was seen.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adgey A. A., Allen J. D., Geddes J. S., James R. G., Webb S. W., Zaidi S. A., Pantridge J. F. Acute phase of myocardial infarction. Lancet. 1971 Sep 4;2(7723):501–504. doi: 10.1016/s0140-6736(71)90434-x. [DOI] [PubMed] [Google Scholar]
  2. Campbell R. W., Murray A., Julian D. G. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J. 1981 Oct;46(4):351–357. doi: 10.1136/hrt.46.4.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carlsson L., Almgren O., Duker G. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions. J Cardiovasc Pharmacol. 1990 Aug;16(2):276–285. doi: 10.1097/00005344-199008000-00014. [DOI] [PubMed] [Google Scholar]
  4. Coker S. J. Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias: effects of quinidine and bretylium. J Pharmacol Methods. 1989 Jul;21(4):263–279. doi: 10.1016/0160-5402(89)90064-8. [DOI] [PubMed] [Google Scholar]
  5. Colatsky T. J., Follmer C. H., Starmer C. F. Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation. 1990 Dec;82(6):2235–2242. doi: 10.1161/01.cir.82.6.2235. [DOI] [PubMed] [Google Scholar]
  6. Colatsky T. J. The Sicilian Gambit and antiarrhythmic drug development. Cardiovasc Res. 1992 Jun;26(6):562–565. doi: 10.1093/cvr/26.6.562. [DOI] [PubMed] [Google Scholar]
  7. Curtis M. J., Hearse D. J. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol. 1989 Jan;21(1):21–40. doi: 10.1016/0022-2828(89)91490-9. [DOI] [PubMed] [Google Scholar]
  8. Curtis M. J., Hearse D. J. Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol. 1989 Jun;21(6):625–637. doi: 10.1016/0022-2828(89)90828-6. [DOI] [PubMed] [Google Scholar]
  9. Curtis M. J. The rabbit dual coronary perfusion model: a new method for assessing the pathological relevance of individual products of the ischaemic milieu: role of potassium in arrhythmogenesis. Cardiovasc Res. 1991 Dec;25(12):1010–1022. doi: 10.1093/cvr/25.12.1010. [DOI] [PubMed] [Google Scholar]
  10. Curtis M. J. Torsades de pointes: arrhythmia, syndrome, or chimera? A perspective in the light of the Lambeth Conventions. Cardiovasc Drugs Ther. 1991 Feb;5(1):191–200. doi: 10.1007/BF03029820. [DOI] [PubMed] [Google Scholar]
  11. Curtis M. J., Walker M. J. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res. 1988 Sep;22(9):656–665. doi: 10.1093/cvr/22.9.656. [DOI] [PubMed] [Google Scholar]
  12. Dessertenne F. La tachycardie ventriculaire à deux foyers opposés variables. Arch Mal Coeur Vaiss. 1966 Feb;59(2):263–272. [PubMed] [Google Scholar]
  13. Dukes I. D., Cleemann L., Morad M. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells. J Pharmacol Exp Ther. 1990 Aug;254(2):560–569. [PubMed] [Google Scholar]
  14. Ferrier G. R., Moffat M. P., Lukas A. Possible mechanisms of ventricular arrhythmias elicited by ischemia followed by reperfusion. Studies on isolated canine ventricular tissues. Circ Res. 1985 Feb;56(2):184–194. doi: 10.1161/01.res.56.2.184. [DOI] [PubMed] [Google Scholar]
  15. Galiñanes M., Hearse D. J. Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection. Cardioscience. 1990 Jun;1(2):127–143. [PubMed] [Google Scholar]
  16. Gwilt M., Dalrymple H. W., Burges R. A., Blackburn K. J., Dickinson R. P., Cross P. E., Higgins A. J. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent. J Cardiovasc Pharmacol. 1991 Mar;17(3):376–385. doi: 10.1097/00005344-199103000-00004. [DOI] [PubMed] [Google Scholar]
  17. Hirche H., Franz C., Bös L., Bissig R., Lang R., Schramm M. Myocardial extracellular K+ and H+ increase and noradrenaline release as possible cause of early arrhythmias following acute coronary artery occlusion in pigs. J Mol Cell Cardiol. 1980 Jun;12(6):579–593. doi: 10.1016/0022-2828(80)90016-4. [DOI] [PubMed] [Google Scholar]
  18. Janse M. J., Kleber A. G., Capucci A., Coronel R., Wilms-Schopman F. Electrophysiological basis for arrhythmias caused by acute ischemia. Role of the subendocardium. J Mol Cell Cardiol. 1986 Apr;18(4):339–355. doi: 10.1016/s0022-2828(86)80898-7. [DOI] [PubMed] [Google Scholar]
  19. Kantor P. F., Coetzee W. A., Carmeliet E. E., Dennis S. C., Opie L. H. Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ Res. 1990 Feb;66(2):478–485. doi: 10.1161/01.res.66.2.478. [DOI] [PubMed] [Google Scholar]
  20. Mason J. W., Hondeghem L. M., Katzung B. G. Amiodarone blocks inactivated cardiac sodium channels. Pflugers Arch. 1983 Jan;396(1):79–81. doi: 10.1007/BF00584702. [DOI] [PubMed] [Google Scholar]
  21. McKibbin J. K., Pocock W. A., Barlow J. B., Millar R. N., Obel I. W. Sotalol, hypokalaemia, syncope, and torsade de pointes. Br Heart J. 1984 Feb;51(2):157–162. doi: 10.1136/hrt.51.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sanguinetti M. C., Jurkiewicz N. K. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990 Jul;96(1):195–215. doi: 10.1085/jgp.96.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Singh B. N., Nademanee K. Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations. Am Heart J. 1985 Feb;109(2):421–430. doi: 10.1016/0002-8703(85)90629-5. [DOI] [PubMed] [Google Scholar]
  24. Tanaka K., Hearse D. J. Reperfusion-induced arrhythmias in the isolated rabbit heart: characterization of the influence of the duration of regional ischemia and the extracellular potassium concentration. J Mol Cell Cardiol. 1988 Mar;20(3):201–211. doi: 10.1016/s0022-2828(88)80053-1. [DOI] [PubMed] [Google Scholar]
  25. Tande P. M., Bjørnstad H., Yang T., Refsum H. Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol. 1990 Sep;16(3):401–410. doi: 10.1097/00005344-199009000-00008. [DOI] [PubMed] [Google Scholar]
  26. Tsuchihashi K., Curtis M. J. Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: chemical defibrillation by Ito blockade? J Cardiovasc Pharmacol. 1991 Sep;18(3):445–456. doi: 10.1097/00005344-199109000-00018. [DOI] [PubMed] [Google Scholar]
  27. Tzivoni D., Keren A., Granot H., Gottlieb S., Benhorin J., Stern S. Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina. Am Heart J. 1983 Feb;105(2):323–325. doi: 10.1016/0002-8703(83)90534-3. [DOI] [PubMed] [Google Scholar]
  28. Walker M. J., Curtis M. J., Hearse D. J., Campbell R. W., Janse M. J., Yellon D. M., Cobbe S. M., Coker S. J., Harness J. B., Harron D. W. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res. 1988 Jul;22(7):447–455. doi: 10.1093/cvr/22.7.447. [DOI] [PubMed] [Google Scholar]
  29. Watanabe I., Johnson T. A., Buchanan J., Engle C. L., Gettes L. S. Effect of graded coronary flow reduction on ionic, electrical, and mechanical indexes of ischemia in the pig. Circulation. 1987 Nov;76(5):1127–1134. doi: 10.1161/01.cir.76.5.1127. [DOI] [PubMed] [Google Scholar]
  30. Yang T., Tande P. M., Refsum H. Negative chronotropic effect of a novel class III antiarrhythmic drug, UK-68,798, devoid of beta-blocking action on isolated guinea-pig atria. Br J Pharmacol. 1991 Jun;103(2):1417–1420. doi: 10.1111/j.1476-5381.1991.tb09804.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Zbinden G., Kleinert R., Rageth B. Assessment of emetine cardiotoxicity in a subacute toxicity experiment in rats. J Cardiovasc Pharmacol. 1980;2(2):155–164. doi: 10.1097/00005344-198003000-00007. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES